1 Study Coverage
    1.1 Prokaryotic Recombinant Protein Product Introduction
    1.2 Market by Type
        1.2.1 Global Prokaryotic Recombinant Protein Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Hormones
        1.2.3 Interferons
        1.2.4 Interleukins
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Prokaryotic Recombinant Protein Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Biotechnology Companies
        1.3.3 Research institutes
        1.3.4 Contract Research organizations
        1.3.5 Hospital
        1.3.6 Laboratories
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Prokaryotic Recombinant Protein Sales Estimates and Forecasts 2017-2028
    2.2 Global Prokaryotic Recombinant Protein Revenue Estimates and Forecasts 2017-2028
    2.3 Global Prokaryotic Recombinant Protein Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Prokaryotic Recombinant Protein Sales by Region
        2.4.1 Global Prokaryotic Recombinant Protein Sales by Region (2017-2022)
        2.4.2 Global Sales Prokaryotic Recombinant Protein by Region (2023-2028)
    2.5 Global Prokaryotic Recombinant Protein Revenue by Region
        2.5.1 Global Prokaryotic Recombinant Protein Revenue by Region (2017-2022)
        2.5.2 Global Prokaryotic Recombinant Protein Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Prokaryotic Recombinant Protein Sales by Manufacturers
        3.1.1 Global Top Prokaryotic Recombinant Protein Manufacturers by Sales (2017-2022)
        3.1.2 Global Prokaryotic Recombinant Protein Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prokaryotic Recombinant Protein in 2021
    3.2 Global Prokaryotic Recombinant Protein Revenue by Manufacturers
        3.2.1 Global Prokaryotic Recombinant Protein Revenue by Manufacturers (2017-2022)
        3.2.2 Global Prokaryotic Recombinant Protein Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Prokaryotic Recombinant Protein Revenue in 2021
    3.3 Global Prokaryotic Recombinant Protein Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Prokaryotic Recombinant Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Prokaryotic Recombinant Protein Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Prokaryotic Recombinant Protein Sales by Type
        4.1.1 Global Prokaryotic Recombinant Protein Historical Sales by Type (2017-2022)
        4.1.2 Global Prokaryotic Recombinant Protein Forecasted Sales by Type (2023-2028)
        4.1.3 Global Prokaryotic Recombinant Protein Sales Market Share by Type (2017-2028)
    4.2 Global Prokaryotic Recombinant Protein Revenue by Type
        4.2.1 Global Prokaryotic Recombinant Protein Historical Revenue by Type (2017-2022)
        4.2.2 Global Prokaryotic Recombinant Protein Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Prokaryotic Recombinant Protein Revenue Market Share by Type (2017-2028)
    4.3 Global Prokaryotic Recombinant Protein Price by Type
        4.3.1 Global Prokaryotic Recombinant Protein Price by Type (2017-2022)
        4.3.2 Global Prokaryotic Recombinant Protein Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Prokaryotic Recombinant Protein Sales by Application
        5.1.1 Global Prokaryotic Recombinant Protein Historical Sales by Application (2017-2022)
        5.1.2 Global Prokaryotic Recombinant Protein Forecasted Sales by Application (2023-2028)
        5.1.3 Global Prokaryotic Recombinant Protein Sales Market Share by Application (2017-2028)
    5.2 Global Prokaryotic Recombinant Protein Revenue by Application
        5.2.1 Global Prokaryotic Recombinant Protein Historical Revenue by Application (2017-2022)
        5.2.2 Global Prokaryotic Recombinant Protein Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Prokaryotic Recombinant Protein Revenue Market Share by Application (2017-2028)
    5.3 Global Prokaryotic Recombinant Protein Price by Application
        5.3.1 Global Prokaryotic Recombinant Protein Price by Application (2017-2022)
        5.3.2 Global Prokaryotic Recombinant Protein Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Prokaryotic Recombinant Protein Market Size by Type
        6.1.1 North America Prokaryotic Recombinant Protein Sales by Type (2017-2028)
        6.1.2 North America Prokaryotic Recombinant Protein Revenue by Type (2017-2028)
    6.2 North America Prokaryotic Recombinant Protein Market Size by Application
        6.2.1 North America Prokaryotic Recombinant Protein Sales by Application (2017-2028)
        6.2.2 North America Prokaryotic Recombinant Protein Revenue by Application (2017-2028)
    6.3 North America Prokaryotic Recombinant Protein Market Size by Country
        6.3.1 North America Prokaryotic Recombinant Protein Sales by Country (2017-2028)
        6.3.2 North America Prokaryotic Recombinant Protein Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Prokaryotic Recombinant Protein Market Size by Type
        7.1.1 Europe Prokaryotic Recombinant Protein Sales by Type (2017-2028)
        7.1.2 Europe Prokaryotic Recombinant Protein Revenue by Type (2017-2028)
    7.2 Europe Prokaryotic Recombinant Protein Market Size by Application
        7.2.1 Europe Prokaryotic Recombinant Protein Sales by Application (2017-2028)
        7.2.2 Europe Prokaryotic Recombinant Protein Revenue by Application (2017-2028)
    7.3 Europe Prokaryotic Recombinant Protein Market Size by Country
        7.3.1 Europe Prokaryotic Recombinant Protein Sales by Country (2017-2028)
        7.3.2 Europe Prokaryotic Recombinant Protein Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Prokaryotic Recombinant Protein Market Size by Type
        8.1.1 Asia Pacific Prokaryotic Recombinant Protein Sales by Type (2017-2028)
        8.1.2 Asia Pacific Prokaryotic Recombinant Protein Revenue by Type (2017-2028)
    8.2 Asia Pacific Prokaryotic Recombinant Protein Market Size by Application
        8.2.1 Asia Pacific Prokaryotic Recombinant Protein Sales by Application (2017-2028)
        8.2.2 Asia Pacific Prokaryotic Recombinant Protein Revenue by Application (2017-2028)
    8.3 Asia Pacific Prokaryotic Recombinant Protein Market Size by Region
        8.3.1 Asia Pacific Prokaryotic Recombinant Protein Sales by Region (2017-2028)
        8.3.2 Asia Pacific Prokaryotic Recombinant Protein Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Prokaryotic Recombinant Protein Market Size by Type
        9.1.1 Latin America Prokaryotic Recombinant Protein Sales by Type (2017-2028)
        9.1.2 Latin America Prokaryotic Recombinant Protein Revenue by Type (2017-2028)
    9.2 Latin America Prokaryotic Recombinant Protein Market Size by Application
        9.2.1 Latin America Prokaryotic Recombinant Protein Sales by Application (2017-2028)
        9.2.2 Latin America Prokaryotic Recombinant Protein Revenue by Application (2017-2028)
    9.3 Latin America Prokaryotic Recombinant Protein Market Size by Country
        9.3.1 Latin America Prokaryotic Recombinant Protein Sales by Country (2017-2028)
        9.3.2 Latin America Prokaryotic Recombinant Protein Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Prokaryotic Recombinant Protein Market Size by Type
        10.1.1 Middle East and Africa Prokaryotic Recombinant Protein Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Prokaryotic Recombinant Protein Revenue by Type (2017-2028)
    10.2 Middle East and Africa Prokaryotic Recombinant Protein Market Size by Application
        10.2.1 Middle East and Africa Prokaryotic Recombinant Protein Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Prokaryotic Recombinant Protein Revenue by Application (2017-2028)
    10.3 Middle East and Africa Prokaryotic Recombinant Protein Market Size by Country
        10.3.1 Middle East and Africa Prokaryotic Recombinant Protein Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Prokaryotic Recombinant Protein Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Eli Lilly and Company
        11.1.1 Eli Lilly and Company Corporation Information
        11.1.2 Eli Lilly and Company Overview
        11.1.3 Eli Lilly and Company Prokaryotic Recombinant Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Eli Lilly and Company Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Eli Lilly and Company Recent Developments
    11.2 Merck
        11.2.1 Merck Corporation Information
        11.2.2 Merck Overview
        11.2.3 Merck Prokaryotic Recombinant Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Merck Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Merck Recent Developments
    11.3 Roche
        11.3.1 Roche Corporation Information
        11.3.2 Roche Overview
        11.3.3 Roche Prokaryotic Recombinant Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Roche Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Roche Recent Developments
    11.4 Prospec-Tany Technogene
        11.4.1 Prospec-Tany Technogene Corporation Information
        11.4.2 Prospec-Tany Technogene Overview
        11.4.3 Prospec-Tany Technogene Prokaryotic Recombinant Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Prospec-Tany Technogene Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Prospec-Tany Technogene Recent Developments
    11.5 Cusabio Technology
        11.5.1 Cusabio Technology Corporation Information
        11.5.2 Cusabio Technology Overview
        11.5.3 Cusabio Technology Prokaryotic Recombinant Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Cusabio Technology Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Cusabio Technology Recent Developments
    11.6 Randox Laboratories
        11.6.1 Randox Laboratories Corporation Information
        11.6.2 Randox Laboratories Overview
        11.6.3 Randox Laboratories Prokaryotic Recombinant Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Randox Laboratories Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Randox Laboratories Recent Developments
    11.7 Batavia Biosciences
        11.7.1 Batavia Biosciences Corporation Information
        11.7.2 Batavia Biosciences Overview
        11.7.3 Batavia Biosciences Prokaryotic Recombinant Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Batavia Biosciences Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Batavia Biosciences Recent Developments
    11.8 Geno Technology
        11.8.1 Geno Technology Corporation Information
        11.8.2 Geno Technology Overview
        11.8.3 Geno Technology Prokaryotic Recombinant Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Geno Technology Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Geno Technology Recent Developments
    11.9 Kaneka and Eurogentec
        11.9.1 Kaneka and Eurogentec Corporation Information
        11.9.2 Kaneka and Eurogentec Overview
        11.9.3 Kaneka and Eurogentec Prokaryotic Recombinant Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Kaneka and Eurogentec Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Kaneka and Eurogentec Recent Developments
    11.10 Abnova Corporation
        11.10.1 Abnova Corporation Corporation Information
        11.10.2 Abnova Corporation Overview
        11.10.3 Abnova Corporation Prokaryotic Recombinant Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Abnova Corporation Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Abnova Corporation Recent Developments
    11.11 Cayman Chemical Company
        11.11.1 Cayman Chemical Company Corporation Information
        11.11.2 Cayman Chemical Company Overview
        11.11.3 Cayman Chemical Company Prokaryotic Recombinant Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Cayman Chemical Company Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Cayman Chemical Company Recent Developments
    11.12 Geltor IndieBio
        11.12.1 Geltor IndieBio Corporation Information
        11.12.2 Geltor IndieBio Overview
        11.12.3 Geltor IndieBio Prokaryotic Recombinant Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Geltor IndieBio Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Geltor IndieBio Recent Developments
    11.13 Bioclone
        11.13.1 Bioclone Corporation Information
        11.13.2 Bioclone Overview
        11.13.3 Bioclone Prokaryotic Recombinant Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Bioclone Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Bioclone Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Prokaryotic Recombinant Protein Industry Chain Analysis
    12.2 Prokaryotic Recombinant Protein Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Prokaryotic Recombinant Protein Production Mode & Process
    12.4 Prokaryotic Recombinant Protein Sales and Marketing
        12.4.1 Prokaryotic Recombinant Protein Sales Channels
        12.4.2 Prokaryotic Recombinant Protein Distributors
    12.5 Prokaryotic Recombinant Protein Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Prokaryotic Recombinant Protein Industry Trends
    13.2 Prokaryotic Recombinant Protein Market Drivers
    13.3 Prokaryotic Recombinant Protein Market Challenges
    13.4 Prokaryotic Recombinant Protein Market Restraints
14 Key Findings in The Global Prokaryotic Recombinant Protein Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Prokaryotic Recombinant Protein Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Hormones
    Table 3. Major Manufacturers of Interferons
    Table 4. Major Manufacturers of Interleukins
    Table 5. Major Manufacturers of Others
    Table 6. Global Prokaryotic Recombinant Protein Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Prokaryotic Recombinant Protein Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Prokaryotic Recombinant Protein Sales by Region (2017-2022) & (Kg)
    Table 9. Global Prokaryotic Recombinant Protein Sales Market Share by Region (2017-2022)
    Table 10. Global Prokaryotic Recombinant Protein Sales by Region (2023-2028) & (Kg)
    Table 11. Global Prokaryotic Recombinant Protein Sales Market Share by Region (2023-2028)
    Table 12. Global Prokaryotic Recombinant Protein Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Prokaryotic Recombinant Protein Revenue Market Share by Region (2017-2022)
    Table 14. Global Prokaryotic Recombinant Protein Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Prokaryotic Recombinant Protein Revenue Market Share by Region (2023-2028)
    Table 16. Global Prokaryotic Recombinant Protein Sales by Manufacturers (2017-2022) & (Kg)
    Table 17. Global Prokaryotic Recombinant Protein Sales Share by Manufacturers (2017-2022)
    Table 18. Global Prokaryotic Recombinant Protein Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Prokaryotic Recombinant Protein Revenue Share by Manufacturers (2017-2022)
    Table 20. Prokaryotic Recombinant Protein Price by Manufacturers (2017-2022) &(US$/Kg)
    Table 21. Global Prokaryotic Recombinant Protein Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Prokaryotic Recombinant Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prokaryotic Recombinant Protein as of 2021)
    Table 23. Prokaryotic Recombinant Protein Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Prokaryotic Recombinant Protein Product Offered
    Table 25. Date of Manufacturers Enter into Prokaryotic Recombinant Protein Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Prokaryotic Recombinant Protein Sales by Type (2017-2022) & (Kg)
    Table 28. Global Prokaryotic Recombinant Protein Sales by Type (2023-2028) & (Kg)
    Table 29. Global Prokaryotic Recombinant Protein Sales Share by Type (2017-2022)
    Table 30. Global Prokaryotic Recombinant Protein Sales Share by Type (2023-2028)
    Table 31. Global Prokaryotic Recombinant Protein Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Prokaryotic Recombinant Protein Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Prokaryotic Recombinant Protein Revenue Share by Type (2017-2022)
    Table 34. Global Prokaryotic Recombinant Protein Revenue Share by Type (2023-2028)
    Table 35. Prokaryotic Recombinant Protein Price by Type (2017-2022) & (US$/Kg)
    Table 36. Global Prokaryotic Recombinant Protein Price Forecast by Type (2023-2028) & (US$/Kg)
    Table 37. Global Prokaryotic Recombinant Protein Sales by Application (2017-2022) & (Kg)
    Table 38. Global Prokaryotic Recombinant Protein Sales by Application (2023-2028) & (Kg)
    Table 39. Global Prokaryotic Recombinant Protein Sales Share by Application (2017-2022)
    Table 40. Global Prokaryotic Recombinant Protein Sales Share by Application (2023-2028)
    Table 41. Global Prokaryotic Recombinant Protein Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Prokaryotic Recombinant Protein Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Prokaryotic Recombinant Protein Revenue Share by Application (2017-2022)
    Table 44. Global Prokaryotic Recombinant Protein Revenue Share by Application (2023-2028)
    Table 45. Prokaryotic Recombinant Protein Price by Application (2017-2022) & (US$/Kg)
    Table 46. Global Prokaryotic Recombinant Protein Price Forecast by Application (2023-2028) & (US$/Kg)
    Table 47. North America Prokaryotic Recombinant Protein Sales by Type (2017-2022) & (Kg)
    Table 48. North America Prokaryotic Recombinant Protein Sales by Type (2023-2028) & (Kg)
    Table 49. North America Prokaryotic Recombinant Protein Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Prokaryotic Recombinant Protein Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Prokaryotic Recombinant Protein Sales by Application (2017-2022) & (Kg)
    Table 52. North America Prokaryotic Recombinant Protein Sales by Application (2023-2028) & (Kg)
    Table 53. North America Prokaryotic Recombinant Protein Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Prokaryotic Recombinant Protein Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Prokaryotic Recombinant Protein Sales by Country (2017-2022) & (Kg)
    Table 56. North America Prokaryotic Recombinant Protein Sales by Country (2023-2028) & (Kg)
    Table 57. North America Prokaryotic Recombinant Protein Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Prokaryotic Recombinant Protein Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Prokaryotic Recombinant Protein Sales by Type (2017-2022) & (Kg)
    Table 60. Europe Prokaryotic Recombinant Protein Sales by Type (2023-2028) & (Kg)
    Table 61. Europe Prokaryotic Recombinant Protein Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Prokaryotic Recombinant Protein Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Prokaryotic Recombinant Protein Sales by Application (2017-2022) & (Kg)
    Table 64. Europe Prokaryotic Recombinant Protein Sales by Application (2023-2028) & (Kg)
    Table 65. Europe Prokaryotic Recombinant Protein Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Prokaryotic Recombinant Protein Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Prokaryotic Recombinant Protein Sales by Country (2017-2022) & (Kg)
    Table 68. Europe Prokaryotic Recombinant Protein Sales by Country (2023-2028) & (Kg)
    Table 69. Europe Prokaryotic Recombinant Protein Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Prokaryotic Recombinant Protein Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Prokaryotic Recombinant Protein Sales by Type (2017-2022) & (Kg)
    Table 72. Asia Pacific Prokaryotic Recombinant Protein Sales by Type (2023-2028) & (Kg)
    Table 73. Asia Pacific Prokaryotic Recombinant Protein Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Prokaryotic Recombinant Protein Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Prokaryotic Recombinant Protein Sales by Application (2017-2022) & (Kg)
    Table 76. Asia Pacific Prokaryotic Recombinant Protein Sales by Application (2023-2028) & (Kg)
    Table 77. Asia Pacific Prokaryotic Recombinant Protein Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Prokaryotic Recombinant Protein Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Prokaryotic Recombinant Protein Sales by Region (2017-2022) & (Kg)
    Table 80. Asia Pacific Prokaryotic Recombinant Protein Sales by Region (2023-2028) & (Kg)
    Table 81. Asia Pacific Prokaryotic Recombinant Protein Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Prokaryotic Recombinant Protein Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Prokaryotic Recombinant Protein Sales by Type (2017-2022) & (Kg)
    Table 84. Latin America Prokaryotic Recombinant Protein Sales by Type (2023-2028) & (Kg)
    Table 85. Latin America Prokaryotic Recombinant Protein Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Prokaryotic Recombinant Protein Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Prokaryotic Recombinant Protein Sales by Application (2017-2022) & (Kg)
    Table 88. Latin America Prokaryotic Recombinant Protein Sales by Application (2023-2028) & (Kg)
    Table 89. Latin America Prokaryotic Recombinant Protein Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Prokaryotic Recombinant Protein Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Prokaryotic Recombinant Protein Sales by Country (2017-2022) & (Kg)
    Table 92. Latin America Prokaryotic Recombinant Protein Sales by Country (2023-2028) & (Kg)
    Table 93. Latin America Prokaryotic Recombinant Protein Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Prokaryotic Recombinant Protein Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Prokaryotic Recombinant Protein Sales by Type (2017-2022) & (Kg)
    Table 96. Middle East and Africa Prokaryotic Recombinant Protein Sales by Type (2023-2028) & (Kg)
    Table 97. Middle East and Africa Prokaryotic Recombinant Protein Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Prokaryotic Recombinant Protein Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Prokaryotic Recombinant Protein Sales by Application (2017-2022) & (Kg)
    Table 100. Middle East and Africa Prokaryotic Recombinant Protein Sales by Application (2023-2028) & (Kg)
    Table 101. Middle East and Africa Prokaryotic Recombinant Protein Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Prokaryotic Recombinant Protein Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Prokaryotic Recombinant Protein Sales by Country (2017-2022) & (Kg)
    Table 104. Middle East and Africa Prokaryotic Recombinant Protein Sales by Country (2023-2028) & (Kg)
    Table 105. Middle East and Africa Prokaryotic Recombinant Protein Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Prokaryotic Recombinant Protein Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Eli Lilly and Company Corporation Information
    Table 108. Eli Lilly and Company Description and Major Businesses
    Table 109. Eli Lilly and Company Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 110. Eli Lilly and Company Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Eli Lilly and Company Recent Developments
    Table 112. Merck Corporation Information
    Table 113. Merck Description and Major Businesses
    Table 114. Merck Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 115. Merck Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Merck Recent Developments
    Table 117. Roche Corporation Information
    Table 118. Roche Description and Major Businesses
    Table 119. Roche Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 120. Roche Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Roche Recent Developments
    Table 122. Prospec-Tany Technogene Corporation Information
    Table 123. Prospec-Tany Technogene Description and Major Businesses
    Table 124. Prospec-Tany Technogene Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 125. Prospec-Tany Technogene Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Prospec-Tany Technogene Recent Developments
    Table 127. Cusabio Technology Corporation Information
    Table 128. Cusabio Technology Description and Major Businesses
    Table 129. Cusabio Technology Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 130. Cusabio Technology Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Cusabio Technology Recent Developments
    Table 132. Randox Laboratories Corporation Information
    Table 133. Randox Laboratories Description and Major Businesses
    Table 134. Randox Laboratories Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 135. Randox Laboratories Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Randox Laboratories Recent Developments
    Table 137. Batavia Biosciences Corporation Information
    Table 138. Batavia Biosciences Description and Major Businesses
    Table 139. Batavia Biosciences Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 140. Batavia Biosciences Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Batavia Biosciences Recent Developments
    Table 142. Geno Technology Corporation Information
    Table 143. Geno Technology Description and Major Businesses
    Table 144. Geno Technology Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 145. Geno Technology Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Geno Technology Recent Developments
    Table 147. Kaneka and Eurogentec Corporation Information
    Table 148. Kaneka and Eurogentec Description and Major Businesses
    Table 149. Kaneka and Eurogentec Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 150. Kaneka and Eurogentec Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Kaneka and Eurogentec Recent Developments
    Table 152. Abnova Corporation Corporation Information
    Table 153. Abnova Corporation Description and Major Businesses
    Table 154. Abnova Corporation Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 155. Abnova Corporation Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Abnova Corporation Recent Developments
    Table 157. Cayman Chemical Company Corporation Information
    Table 158. Cayman Chemical Company Description and Major Businesses
    Table 159. Cayman Chemical Company Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 160. Cayman Chemical Company Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Cayman Chemical Company Recent Developments
    Table 162. Geltor IndieBio Corporation Information
    Table 163. Geltor IndieBio Description and Major Businesses
    Table 164. Geltor IndieBio Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 165. Geltor IndieBio Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Geltor IndieBio Recent Developments
    Table 167. Bioclone Corporation Information
    Table 168. Bioclone Description and Major Businesses
    Table 169. Bioclone Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 170. Bioclone Prokaryotic Recombinant Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. Bioclone Recent Developments
    Table 172. Key Raw Materials Lists
    Table 173. Raw Materials Key Suppliers Lists
    Table 174. Prokaryotic Recombinant Protein Distributors List
    Table 175. Prokaryotic Recombinant Protein Customers List
    Table 176. Prokaryotic Recombinant Protein Market Trends
    Table 177. Prokaryotic Recombinant Protein Market Drivers
    Table 178. Prokaryotic Recombinant Protein Market Challenges
    Table 179. Prokaryotic Recombinant Protein Market Restraints
    Table 180. Research Programs/Design for This Report
    Table 181. Key Data Information from Secondary Sources
    Table 182. Key Data Information from Primary Sources
List of Figures
    Figure 1. Prokaryotic Recombinant Protein Product Picture
    Figure 3. Global Prokaryotic Recombinant Protein Market Share by Type in 2021 & 2028
    Figure 3. Hormones Product Picture
    Figure 4. Interferons Product Picture
    Figure 5. Interleukins Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Prokaryotic Recombinant Protein Market Share by Application in 2021 & 2028
    Figure 8. Biotechnology Companies
    Figure 9. Research institutes
    Figure 10. Contract Research organizations
    Figure 11. Hospital
    Figure 12. Laboratories
    Figure 13. Others
    Figure 14. Prokaryotic Recombinant Protein Report Years Considered
    Figure 15. Global Prokaryotic Recombinant Protein Sales 2017-2028 (Kg)
    Figure 16. Global Prokaryotic Recombinant Protein Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Prokaryotic Recombinant Protein Revenue 2017-2028 (US$ Million)
    Figure 18. Global Prokaryotic Recombinant Protein Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 19. Global Prokaryotic Recombinant Protein Sales Market Share by Region (2017-2022)
    Figure 20. Global Prokaryotic Recombinant Protein Sales Market Share by Region (2023-2028)
    Figure 21. North America Prokaryotic Recombinant Protein Sales YoY (2017-2028) & (Kg)
    Figure 22. North America Prokaryotic Recombinant Protein Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Prokaryotic Recombinant Protein Sales YoY (2017-2028) & (Kg)
    Figure 24. Europe Prokaryotic Recombinant Protein Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Asia-Pacific Prokaryotic Recombinant Protein Sales YoY (2017-2028) & (Kg)
    Figure 26. Asia-Pacific Prokaryotic Recombinant Protein Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Latin America Prokaryotic Recombinant Protein Sales YoY (2017-2028) & (Kg)
    Figure 28. Latin America Prokaryotic Recombinant Protein Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Middle East & Africa Prokaryotic Recombinant Protein Sales YoY (2017-2028) & (Kg)
    Figure 30. Middle East & Africa Prokaryotic Recombinant Protein Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. The Prokaryotic Recombinant Protein Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 32. The Top 5 and 10 Largest Manufacturers of Prokaryotic Recombinant Protein in the World: Market Share by Prokaryotic Recombinant Protein Revenue in 2021
    Figure 33. Global Prokaryotic Recombinant Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 34. Global Prokaryotic Recombinant Protein Sales Market Share by Type (2017-2028)
    Figure 35. Global Prokaryotic Recombinant Protein Revenue Market Share by Type (2017-2028)
    Figure 36. Global Prokaryotic Recombinant Protein Sales Market Share by Application (2017-2028)
    Figure 37. Global Prokaryotic Recombinant Protein Revenue Market Share by Application (2017-2028)
    Figure 38. North America Prokaryotic Recombinant Protein Sales Market Share by Type (2017-2028)
    Figure 39. North America Prokaryotic Recombinant Protein Revenue Market Share by Type (2017-2028)
    Figure 40. North America Prokaryotic Recombinant Protein Sales Market Share by Application (2017-2028)
    Figure 41. North America Prokaryotic Recombinant Protein Revenue Market Share by Application (2017-2028)
    Figure 42. North America Prokaryotic Recombinant Protein Sales Share by Country (2017-2028)
    Figure 43. North America Prokaryotic Recombinant Protein Revenue Share by Country (2017-2028)
    Figure 44. U.S. Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 45. Canada Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 46. Europe Prokaryotic Recombinant Protein Sales Market Share by Type (2017-2028)
    Figure 47. Europe Prokaryotic Recombinant Protein Revenue Market Share by Type (2017-2028)
    Figure 48. Europe Prokaryotic Recombinant Protein Sales Market Share by Application (2017-2028)
    Figure 49. Europe Prokaryotic Recombinant Protein Revenue Market Share by Application (2017-2028)
    Figure 50. Europe Prokaryotic Recombinant Protein Sales Share by Country (2017-2028)
    Figure 51. Europe Prokaryotic Recombinant Protein Revenue Share by Country (2017-2028)
    Figure 52. Germany Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 53. France Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 54. U.K. Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 55. Italy Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 56. Russia Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Prokaryotic Recombinant Protein Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Prokaryotic Recombinant Protein Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Prokaryotic Recombinant Protein Sales Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Prokaryotic Recombinant Protein Revenue Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Prokaryotic Recombinant Protein Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Prokaryotic Recombinant Protein Revenue Share by Region (2017-2028)
    Figure 63. China Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 66. India Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 68. Taiwan Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 72. Philippines Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 73. Latin America Prokaryotic Recombinant Protein Sales Market Share by Type (2017-2028)
    Figure 74. Latin America Prokaryotic Recombinant Protein Revenue Market Share by Type (2017-2028)
    Figure 75. Latin America Prokaryotic Recombinant Protein Sales Market Share by Application (2017-2028)
    Figure 76. Latin America Prokaryotic Recombinant Protein Revenue Market Share by Application (2017-2028)
    Figure 77. Latin America Prokaryotic Recombinant Protein Sales Share by Country (2017-2028)
    Figure 78. Latin America Prokaryotic Recombinant Protein Revenue Share by Country (2017-2028)
    Figure 79. Mexico Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 80. Brazil Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 81. Argentina Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 82. Middle East and Africa Prokaryotic Recombinant Protein Sales Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Prokaryotic Recombinant Protein Revenue Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Prokaryotic Recombinant Protein Sales Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Prokaryotic Recombinant Protein Revenue Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Prokaryotic Recombinant Protein Sales Share by Country (2017-2028)
    Figure 87. Middle East and Africa Prokaryotic Recombinant Protein Revenue Share by Country (2017-2028)
    Figure 88. Turkey Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 89. Saudi Arabia Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 90. UAE Prokaryotic Recombinant Protein Revenue (2017-2028) & (US$ Million)
    Figure 91. Prokaryotic Recombinant Protein Value Chain
    Figure 92. Prokaryotic Recombinant Protein Production Process
    Figure 93. Channels of Distribution
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed